- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/542 - Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
Patent holdings for IPC class G01N 33/542
Total number of patents in this class: 1284
10-year publication summary
|
90
|
78
|
99
|
102
|
105
|
108
|
82
|
90
|
82
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
33 |
| Centre National de La Recherche Scientifique | 9632 |
30 |
| Promega Corporation | 548 |
28 |
| Ventana Medical Systems, Inc. | 972 |
20 |
| Bio-Rad Laboratories, Inc. | 1592 |
17 |
| Massachusetts Institute of Technology | 9795 |
14 |
| Biomadison, Inc. | 48 |
14 |
| Cisbio Bioassays | 67 |
14 |
| Technische Universiteit Eindhoven | 316 |
13 |
| Becton, Dickinson and Company | 6712 |
12 |
| Procisedx Inc. | 22 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
10 |
| Board of Regents, The University of Texas System | 5370 |
10 |
| The Johns Hopkins University | 5377 |
9 |
| Tokyo Institute of Technology | 1367 |
9 |
| President and Fellows of Harvard College | 5792 |
8 |
| Beckman Coulter, Inc. | 1183 |
8 |
| Medtronic MiniMed, Inc. | 1808 |
7 |
| The General Hospital Corporation | 4517 |
7 |
| Other owners | 998 |